INTERNATIONAL PATENT: ALNYLAM PHARMACEUTICALS, INC. FILES APPLICATION FOR "IRNA COMPOSITIONS AND METHODS FOR SILENCING GROWTH FACTOR RECEPTOR BOUND PROTEIN 14 (GRB14) IN THE LIVER"

GENEVA, Oct. 1 -- ALNYLAM PHARMACEUTICALS, INC. (675 West Kendall StreetHenri A. Termeer SquareCambridge, Massachusetts 02142) filed a patent application (PCT/US2025/020936) for "IRNA COMPOSITIONS AND METHODS FOR SILENCING GROWTH FACTOR RECEPTOR BOUND PROTEIN 14 (GRB14) IN THE LIVER" on Mar 21, 2025. With publication no. WO/2025/199455, the details related to the patent application was published on Sep 25, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BONDURANT, Lucas (c/o Alnylam Pharmaceuticals, Inc.675 West Kendall StreetHenri A. Termeer SquareCambridge, Massachusetts 02142), MCININCH, ...